ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: back pain

Research Links Macrophages with Pathogenesis of Inflammation, Fibrosis

Thomas R. Collins  |  October 17, 2017

MADRID—Research into pharmacodynamic biomarkers has shown that macrophages may have an important role in the pathogenesis of several diseases, including systemic sclerosis, an expert said at the 2017 Annual European Congress on Rheumatology (EULAR). The findings were discussed in a session that also covered how an understanding of M1 macrophages’ role in fibrosis has evolved…

Filed under:ConditionsMeeting ReportsOther Rheumatic ConditionsResearch Rheum Tagged with:BiomarkersEULARfibrosisinflammationmacrophagemeeting reportsPathogenesispharmacodynamicpredictResearchRheumatic Diseaserheumatologyskin diseaseskin scoreSystemic sclerosis

How Juvenile Idiopathic Arthritis Affects Patients, Families

Catherine I. Morlino  |  October 17, 2017

After having had juvenile idiopathic arthritis (JIA) for 20 years, I had a moment in my journey when I realized something new: “Your arthritis doesn’t just affect you, you know,” my sister said. This statement stopped me in my achy tracks. For two decades, I had been operating under the assumption that JIA was my…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:DiagnosisfamilyJIAJuvenile idiopathic arthritisManagementpatient carequality of lifeRheumatic DiseaserheumatologistrheumatologyTreatment

Fellows’ Forum Case Report: Autoinflammatory Diseases and Roles of Genetic, Molecular Testing

Mahjabeen Haq, DO, L. Manuela Marinescu, MD, & Qingping Yao, MD, PhD  |  October 17, 2017

A 51-year-old Caucasian female was referred by a local rheumatologist to the Center of Autoinflammatory Diseases at Stony Brook University, N.Y., for an unusual disease presentation. The patient had had recurrent polyarthritis, fever and rash for the previous three years. She described having a migratory polyarthritis affecting the shoulders, knees, ankles and bilateral forefoot, with…

Filed under:ConditionsOther Rheumatic ConditionsResearch Rheum Tagged with:autoinflammatory diseasecase reportDiagnosisfellowFellowsFellows ForumfevergeneticpolyarthritisrashResearchsystemic inflammatory syndromeYao Syndrome

The AHRP Research Committee Enhances Research Knowledge, Skills for Members

Adam P. Goode, DPT, PhD, & Afton L. Hassett, PsyD  |  October 17, 2017

Editor’s note: The new Pillar Talk column is developed by the ARHP Executive Committee in an effort to share information about ongoing activities related to our four pillars: Education, Practice, Research and Advocacy. The ARHP Research Subcommittee is committed to promoting research and enhancing research opportunities for health professionals and researchers working in rheumatology. A…

Filed under:Interprofessional PerspectiveResearch Rheum Tagged with:AC&RACR Strategic PlanAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)collaborationinvestigatorknowledgemembersResearchrheumatology health professionals

Oksana Shufrych TKTK / Shutterstock.com

Heated Gloves May Improve Hand Function in Diffuse Systemic Sclerosis

Rosemarie Curley, MPT, DPT, & Jeananne Elkins, PT, PhD, DPT, MPH  |  October 16, 2017

Systemic sclerosis (SSc), a subtype of scleroderma, is a rare, complex autoimmune disease characterized by widespread vasculopathy of the small arteries and fibroblast dysfunction.1,2 It has been described as a fibrosing micro­vascular disease, because vascular injury precedes and leads to tissue fibrosis.3 The resulting Raynaud’s phenomenon, pain, skin thickening and tightening, and multi-organ involvement have…

Filed under:ConditionsOther Rheumatic ConditionsResearch Rheum Tagged with:Clinicaldrug therapyhand functionhand warmersheated glovesinterventionnon-pharmaceutical therapiesoutcomepatient careRaynaud’s phenomenonResearchrheumatologistSclerodermastudiesSystemic sclerosistissue fibrosisTreatmentvasculopathy

GlaxoSmithKline’s Shingles Vaccine Gets Approval in Canada

Reuters Staff  |  October 16, 2017

(Reuters)—Canadian health regulators have approved GlaxoSmithKline’s shingles vaccine, the company said on Friday.1 Shingrix, the British pharma company’s shingles vaccine for people aged 50 years or older, was unanimously recommended for approval by a U.S. Food and Drug Administration (FDA) advisory panel last week. Older people are most at risk of an outbreak of shingles,…

Filed under:Drug Updates Tagged with:GlaxoSmithKlineshinglesvaccinationvaricella zoster virus

Tips for Recruiting Rheumatologists

Karen Appold  |  October 13, 2017

Rheumatology is facing a clinician shortage, so attracting the right candidate for your practice may require an aggressive strategy, from recruiting right out of fellowship programs to offering student loan repayment and flexible work schedules…

Filed under:Practice SupportWorkforce Tagged with:employmentfellowshipPractice Managementrecruitmentrheumatologistsrheumatologists fellows

New Jersey Sues Insys as Opioid Maker Settles with Massachusetts

Nate Raymond  |  October 5, 2017

BOSTON (Reuters)—New Jersey on Thursday accused Insys Therapeutics Inc of engaging in a fraudulent scheme to boost sales of a fentanyl-based cancer pain drug, as Massachusetts announced a $500,000 settlement with the drugmaker to resolve similar allegations. The lawsuit by New Jersey Attorney General Christopher Porrino accused Insys of illegally directing its sales force to…

Filed under:Drug UpdatesLegal Updates Tagged with:Cancerfentanyl-based cancer pain drugInsys Therapeutics IncNew Jersey Attorney General Christopher PorrinoNew Jersey lawsuitopioid crisis

Unbudgeted: How the Opioid Crisis Is Blowing a Hole in Small-Town America’s Finances

Paula Seligson & Tim Reid  |  September 20, 2017

INDIANA, Pa./CHILLICOTHE, Ohio (Reuters)—As deaths mount in America’s opioid crisis, communities on the front lines face a hidden toll: the financial cost. Ross County, a largely rural region of 77,000 people an hour south of Columbus, Ohio, is wrestling with an explosion in opioid-related deaths—44 last year compared with 19 in 2009. The drug addiction…

Filed under:AnalgesicsDrug Updates

TNF Inhibitor Drug Tapering Successful in Some Patients with RA

Thomas R. Collins  |  September 19, 2017

MADRID—Scores on the Health Assessment Questionnaire for Rheumatoid Arthritis (HAQ) and C-reactive protein (CRP) levels were independent predictors of whether patients could be tapered successfully from a TNF inhibitor after having reached remission of their RA, according to findings presented in a session at the Annual European Congress of Rheumatology. Researchers also developed a composite…

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:adalimumabAnnual European Congress of RheumatologyClinicaldrugetanerceptEULARglucocorticosteroidMedicationoutcomeResearchRheumatoid arthritistaperingtherapyTNF inhibitorTreatment

  • « Previous Page
  • 1
  • …
  • 110
  • 111
  • 112
  • 113
  • 114
  • …
  • 163
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences